1
Exhibit 32.1
CERTIFICATIONS
OF PRINCIPAL EXECUTIVE
OFFICER AND PRINCIPAL
FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION
906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Vaxxinity,
Inc. (the “Company”) on Form 10-Q for the quarter ended
September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the
undersigned hereby certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of their knowledge:
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.
Date: November 8, 2023
By:
/s/ Mei Mei Hu
President and Chief Executive Officer
(Principal Executive Officer)
Date: November 8, 2023
By:
/s/ Jason Pesile
Senior Vice President, Finance and Accounting
(Principal Financial and Accounting Officer)